Gary A. Lyons, Director: Neurocrine Biosciences NBIX Sell · Filed 23/12/27

Trade details

Type: Insider sale
Amount: $1,300,400
Shares · price: 10,000 sh · $130.04 a share
Held after: 193,697 sh
Stock: Neurocrine Biosciences NBIX
Person: Gary A. LyonsDirector
Trade date: 23/12/22
Filed: 23/12/27
Days to filing: 5 days

Sold 4.9% of holdings

Share of holding sold: 4.9%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/11/22~24/01/21

Gary A. Lyons's recent trades

Gary A. LyonsDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$317.7K
5,000 sh
$317.7K
Filed 08/18
Traded 08/18
Gary A. LyonsDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$310.7K
5,000 sh
$310.7K
Filed 08/17
Traded 08/17
Gary A. LyonsDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$328.6K
8,000 sh
$328.6K
Filed 04/16
Traded 04/14
Gary A. LyonsOfficer
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$245.6K
8,000 sh
$245.6K
Filed 04/14
Traded 04/14
Gary A. LyonsDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$2.3M
15,000 sh
$2.3M
Filed 25/12/04
Traded 25/12/03